Bachelor's in Chemistry, Caltech; MD and PhD, Johns Hopkins University. 2010, joined Pfizer. Former Howard Hughes Investigator, Duke University. Currently, heads Neuroscience R&D. Research focuses on the interface between neuronal cell biology, circuit plasticity and neuropsychiatric disease. At Pfizer, has brought 11 compounds into clinical development in multiple neuroscience disorders.